Caliway Biopharmaceuticals has officially announced that its CBL-514's second Phase 2b clinical study (CBL-0205), which was conducted at different 15 sites across the U.S....
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, has officially published the results from its latest study called...
ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, has officially signed off on an agreement with SWK...
IgniteData, a leader in EHR-to-EDC interoperability for clinical trials, has officially announced a partnership with Yunu to enhance seamless integration of imaging data into...
The US Food and Drug Administration has officially approved AbbVie's EMBLAVEO™ (aztreonam and avibactam) as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination...
